Viewing Study NCT02079818


Ignite Creation Date: 2025-12-25 @ 4:59 AM
Ignite Modification Date: 2026-02-22 @ 7:19 PM
Study NCT ID: NCT02079818
Status: WITHDRAWN
Last Update Posted: 2019-04-12
First Post: 2014-03-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Visceral Artery Aneurysm Embolization by the Penumbra Ruby™ Coil System
Sponsor:
Organization:

Raw JSON

{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D001165', 'term': 'Arteriovenous Malformations'}], 'ancestors': [{'id': 'D054079', 'term': 'Vascular Malformations'}, {'id': 'D018376', 'term': 'Cardiovascular Abnormalities'}, {'id': 'D002318', 'term': 'Cardiovascular Diseases'}, {'id': 'D014652', 'term': 'Vascular Diseases'}, {'id': 'D000013', 'term': 'Congenital Abnormalities'}, {'id': 'D009358', 'term': 'Congenital, Hereditary, and Neonatal Diseases and Abnormalities'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE4'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'NA', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'SINGLE_GROUP'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 0}}, 'statusModule': {'whyStopped': 'The study was never initiated.', 'overallStatus': 'WITHDRAWN', 'startDateStruct': {'date': '2017-06', 'type': 'ESTIMATED'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2019-04', 'completionDateStruct': {'date': '2018-09', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2019-04-10', 'studyFirstSubmitDate': '2014-03-03', 'studyFirstSubmitQcDate': '2014-03-04', 'lastUpdatePostDateStruct': {'date': '2019-04-12', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2014-03-06', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2018-09', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': '1. Packing density with the number of coils implanted', 'timeFrame': 'During the procedure'}, {'measure': '2. Time of fluoroscopic exposure', 'timeFrame': 'During the procedure'}, {'measure': '3. Procedural device-related serious adverse events at immediate post-procedure', 'timeFrame': 'At immediate post-procedure'}, {'measure': '4. Occlusion of the aneurysm sac or target vessel at immediate post-procedure', 'timeFrame': 'At immediate post-procedure'}, {'measure': '5. Occlusion of the aneurysm sac or target vessel at one year post-procedure', 'timeFrame': 'One year post-procedure'}], 'secondaryOutcomes': [{'measure': '1. Recanalization of the aneurysm sac or target vessel at 4 months post-procedure', 'timeFrame': '4 months post-procedure'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': True}, 'conditionsModule': {'keywords': ['visceral artery aneurysms', 'arteriovenous malformations', 'Penumbra Ruby Coil System'], 'conditions': ['Visceral Artery Aneurysms', 'Arteriovenous Malformations']}, 'descriptionModule': {'briefSummary': 'The primary objective of this study is to gather post market data on the Penumbra Ruby Coil System in the treatment of visceral artery aneurysms and arteriovenous malformations. This study is a prospective, multi-center study of patients with visceral artery aneurysms and visceral arteriovenous malformations who are treated by the Penumbra Ruby Coil System. Data for each patient are collected up to 12 months post-procedure for the study.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT', 'OLDER_ADULT'], 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Patients enrolled in this study must be those treated according to the cleared indication for the Penumbra Ruby Coil System for visceral arterial and venous embolizations.\n\nExclusion Criteria:\n\n* Patients in whom endovascular embolization therapies other than Penumbra Coils are used will be excluded from this study.'}, 'identificationModule': {'nctId': 'NCT02079818', 'briefTitle': 'Visceral Artery Aneurysm Embolization by the Penumbra Ruby™ Coil System', 'organization': {'class': 'INDUSTRY', 'fullName': 'Penumbra Inc.'}, 'officialTitle': 'CLP 7463: Visceral Artery Aneurysm Embolization by the Penumbra Ruby™ Coil System', 'orgStudyIdInfo': {'id': 'CLP 7463'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Penumbra Ruby Coil System', 'interventionNames': ['Device: Penumbra Ruby Coil System']}], 'interventions': [{'name': 'Penumbra Ruby Coil System', 'type': 'DEVICE', 'description': 'The Penumbra Ruby™ Coil is a new generation of detachable coils developed by Penumbra Inc. This coil system is specifically designed for the occlusion of aneurysms and vessels that is equivalent to standard platinum coils. This system consists of: an implantable Coil attached to a Detachment Pusher as well as a Detachment Handle. The Detachment Pusher is comprised of a shaft with a radiopaque positioning marker, a Distal Detachment Tip, and a pull wire. The Detachment Handle is used to detach the Coil Implant from the Detachment Pusher. The Penumbra Ruby Coil is designed for endovascular embolization in the peripheral vasculature. Intended users for this device are physicians who have received appropriate training in interventional radiology and endovascular intervention.', 'armGroupLabels': ['Penumbra Ruby Coil System']}]}, 'contactsLocationsModule': {'locations': [{'zip': '53226', 'city': 'Milwaukee', 'state': 'Wisconsin', 'country': 'United States', 'facility': 'Medical College of Wisconsin', 'geoPoint': {'lat': 43.0389, 'lon': -87.90647}}], 'overallOfficials': [{'name': 'Paraq J Patel, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Medical College of Wisconsin'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Penumbra Inc.', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}